← FDA DRUG APPROVALS

FDA ANDA · ANDA209102

BACLOFEN

Sponsor: RUBICON RESEARCH

APPLICATION
ANDA209102
TYPE
ANDA
ORIGINAL APPROVAL
2017-11-28
LATEST ACTION
2024-02-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

BACLOFENPrescription
BACLOFEN 5MG · TABLET · ORAL
BACLOFENPrescription
BACLOFEN 15MG · TABLET · ORAL
BACLOFENPrescription
BACLOFEN 10MG · TABLET · ORAL
BACLOFENPrescription
BACLOFEN 20MG · TABLET · ORAL

Approval history

2024-02-05Manufacturing (CMC) · Supplement 15 · unknownAP
2023-09-12Labeling · Supplement 8 · standardAP
2017-11-28UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →